Sitemap > Breaking Research > GenitoUrinary Tract Disorders
Displaying 551 - 600 of 759 results
- Redefining the role of long-acting phosphodiesterase inhibitor tadalafil in the treatment of diabetic erectile dysfunction.
- Combination of Alfuzosin and Tadalafil Exerts In Vitro an Additive Relaxant Effect on Human Corpus Cavernosum.
- The Efficacy and Safety of Udenafil, a New Selective Phosphodiesterase Type 5 Inhibitor, in Patients with Erectile Dysfunction.
- Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine.
- Synthesis and screening of a cyclic peptide library: Discovery of small-molecule ligands against human prolactin receptor.
- Effective Treatment of Neurogenic Detrusor Dysfunction by Combined High-Dosed Antimuscarinics without Increased Side-Effects.
- 11-(Pyridinylphenyl)steroids-A new class of mixed-profile progesterone agonists/antagonists.
- Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival.
- Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial.
- The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.
- Monoaryl-Substituted Salicylaldoximes as Ligands for Estrogen Receptor beta.
- Rapid Antimicrobial Susceptibility Determination of Uropathogens in Clinical Urine Specimens Using ATP Bioluminescence.
- Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model.
- A Comprehensive Approach Toward Novel Serum Biomarkers for Benign Prostatic Hyperplasia: The MPSA Consortium.
- A Randomised, Placebo-Controlled Study to Assess the Efficacy of Twice-Daily Vardenafil in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
- Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil.
- The Influence of Cardiovascular Disease on Health Related Quality of Life in Men With Prostate Cancer: A 4-Year Followup Study.
- Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
- Altered expression of calcium-activated K and Cl channels in detrusor overactivity of rats with partial bladder outlet obstruction.
- Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat.
- Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
- Focal adhesion kinase expression in ovarian endometriosis.
- Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.
- Interleukin-12 but not interleukin-18 is associated with severe endometriosis.
- Terazosin Therapy for Patients With Female Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Trial.
- Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: A randomized double-blind pilot trial.
- Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivity.
- Does sildenafil cause myocardial infarction or sudden cardiac death?
- Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States.
- Food restriction alters pramipexole-induced yawning, hypothermia, and locomotor activity in rats: Evidence for sensitization of dopamine D2 receptor-mediated effects.
- Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human beta3-Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I.
- Efficient Gene Expression System Using the RTP801 Promoter in the Corpus Cavernosum of High-Cholesterol Diet-Induced Erectile Dysfunction Rats for Gene Therapy.
- Design, Synthesis, and SAR of New Pyrrole-Oxindole Progesterone Receptor Modulators Leading to 5-(7-Fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348).
- Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects.
- Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
- Therapeutic Response after First Month of Tadalafil Treatment Predicts 12 Months Treatment Continuation in Patients with Erectile Dysfunction: Results from the DETECT Study.
- The Use of Old and Recent DSM Definitions of Premature Ejaculation in Observational Studies: A Contribution to the Present Debate for a New Classification of PE in the DSM-V.
- Assessment of Sexual Health in Aging Men in Europe: Development and Validation of the European Male Ageing Study Sexual Function Questionnaire.
- The Functional and Structural Consequences of Cavernous Nerve Injury are Ameliorated by Sildenafil Citrate.
- Contractile Changes of the Clitoral Cavernous Smooth Muscle in Female Rabbits with Experimentally Induced Overactive Bladder.
- Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study.
- Vardenafil in the treatment of erectile dysfunction in outpatients with chronic schizophrenia: a flexible-dose, open-label study.
- Diagnosis and treatment of female sexual dysfunction.
- Monocyte Chemoattractant Protein-1 and Macrophage Inflammatory Protein-1alpha as Possible Biomarkers for the Chronic Pelvic Pain Syndrome.
- Small conductance, Ca2+- activated K+ channel 2 (SK2) is the key functional component of SK channels in mouse urinary bladder.
- The vitamin D receptor agonist elocalcitol up-regulates L-type calcium channel activity in human and rat bladder.
- Antipsychotic-Like Properties of 5-alpha-Reductase Inhibitors.
- Effect of phosphodiesterase type 4 inhibitor rolipram on cyclophosphamide-induced cystitis in rats.
- Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation.
- Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.